FDA Approves PTSD Sleep Device for Nightmares
November 11, 2020
 |
The U.S. Food and Drug Administration granted marketing authorization of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder... |
|
 Continue reading (Members only)
|
|
|
|
|
|
|
|
Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus
April 9, 2020
 |
With the rising rates of COVID-19 (i.e., severe acute respiratory syndrome coronavirus 2) infection and hospitalization across the world, frontline health care workers will continue to face an overwhelming workload throughout the course of this pandemic. This workload, along with the depletion of personal protection equipment, widespread media coverage, lack of specific drugs and feelings of being inadequately supported may contribute to adverse psychological reactions... |
|
Continue reading
|
|
|
|
FDA Approves Lemborexant for Insomnia
January 9, 2020
|
Although the exact reason is unknown, sleep is an essential component of both physical and mental health. Unfortunately, approximately 30% of adults suffer from insomnia -the inability to attain or maintain sleep despite adequate opportunity. Not only do insomnia sufferers have... |
|
Continue reading (Members only)
|
|
|
|
|
|
Remember to Sleep: Circadian Function in Alzheimer's Disease
July 2, 2019
 |
Alzheimer's disease affects approximately 44 million individuals worldwide. This age-related disease is characterized by accumulation of extracellular plaques composed of beta-amyloid protein, intracellular neurofibrillary tangles composed of hyperphosporylated tau protein, severe neuronal loss, and aggressive neuroinflammation. There is currently... |
|
Continue reading (Members only)
|
|